Ligand validation:4TNK

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 4TNK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TNK_SQD_a_412	27%	31%	0.233	0.89	0.96	1.76	3	11	0	0	94%	0.9444
4TNK_SQD_A_413	17%	31%	0.258	0.844	0.96	1.78	3	10	0	0	94%	0.9444
4TNK_SQD_A_414	3%	36%	0.453	0.804	0.95	1.57	3	9	0	0	100%	1
4TNK_SQD_b_602	2%	28%	0.443	0.729	1.02	1.83	4	10	0	0	87%	0.8704
4TNK_SQD_a_401	1%	35%	0.6	0.8	0.95	1.58	3	10	0	0	100%	1
4TNK_SQD_F_103	1%	31%	0.631	0.81	1.04	1.7	3	11	0	0	83%	0.8333
4TNK_SQD_B_622	1%	28%	0.602	0.743	1.05	1.81	3	11	0	0	80%	0.7963
4TNK_SQD_f_103	0%	31%	0.716	0.811	1.02	1.7	3	11	0	0	83%	0.8333
4TNK_SQD_B_627	0%	29%	0.683	0.67	1.01	1.81	3	10	0	0	87%	0.8704
4TNK_SQD_d_403	0%	29%	0.796	0.717	1.04	1.77	3	11	0	0	80%	0.7963
5V2C_SQD_a_413	94%	21%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	78%	20%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	29%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	76%	31%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	76%	29%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	31%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.